99 related articles for article (PubMed ID: 69489)
41. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
42. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
43. Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA).
Cooperband SR; Davis RC; Schmid K; Mannick JA
Transplant Proc; 1969 Mar; 1(1):516-23. PubMed ID: 4109226
[No Abstract] [Full Text] [Related]
44. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
Hirano T; Nordin AA
J Immunol; 1976 Apr; 116(4):1115-22. PubMed ID: 130426
[TBL] [Abstract][Full Text] [Related]
45. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
46. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
Suzuki H; Quintáns J
J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character.
Gajdosová E; Oravec C; Mayer V
Acta Virol; 1981 Jan; 25(1):10-8. PubMed ID: 6165230
[TBL] [Abstract][Full Text] [Related]
48. Effects of IRA in vitro on T- and B-lymphocytes from peripheral blood of patients with connective tissue diseases.
Kosaka S
Tohoku J Exp Med; 1978 Oct; 126(2):151-7. PubMed ID: 82280
[TBL] [Abstract][Full Text] [Related]
49. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.
Glasgow AH; Nimberg RB; Menzoian JO; Saporoschetz I; Cooperband SR; Schmid K; Mannick JA
N Engl J Med; 1974 Dec; 291(24):1263-7. PubMed ID: 4610386
[No Abstract] [Full Text] [Related]
50. Detection of human T-lymphocyte receptor for sheep erythrocytes in immunoregulatory alpha-globulin.
Musatti CC; Daher S; Bernd LA; Mendes NF
J Clin Immunol; 1983 Oct; 3(4):352-8. PubMed ID: 6197425
[TBL] [Abstract][Full Text] [Related]
51. Immunosuppressive factors in serum of patients with gastric carcinoma.
Urushizaki I; Ishitani K; Nagai T; Gocho Y; Koyama R
Gan; 1977 Aug; 68(4):413-21. PubMed ID: 80341
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of secondary immune responses in vivo by immunoregulatory alpha globulin (IRA).
Glasgow AH; Cooperband SR; Occhino JC; Schmid K; Mannick JA
Proc Soc Exp Biol Med; 1971 Nov; 138(2):753-7. PubMed ID: 4107458
[No Abstract] [Full Text] [Related]
53. Editorial: How lymphocytes kill tumor cells.
Allison AC; Ferluga J
N Engl J Med; 1976 Jul; 295(3):165-7. PubMed ID: 1083940
[No Abstract] [Full Text] [Related]
54. Role of normal immunosuppressive protein (NIP) in immunologic surveillance.
Hanna N; Ovadia H; Nelken D
Transplant Proc; 1977 Mar; 9(1):1071-3. PubMed ID: 68563
[No Abstract] [Full Text] [Related]
55. [Immune response inhibiting effect of blood serum in dermatoses].
Somos Z; Regényi B
Orv Hetil; 1975 Sep; 116(37):2184-6. PubMed ID: 52858
[No Abstract] [Full Text] [Related]
56. In vivo host immune to a tumor-specific transplantation antigen induced by Rous sarcoma virus.
Bellone CJ; Pollard M
J Natl Cancer Inst; 1976 Jan; 56(1):79-82. PubMed ID: 56445
[TBL] [Abstract][Full Text] [Related]
57. Serum proteins in prostatic cancer VI. Reduction of the suppressive ("blocking"?) properties of serum on in vitro parameters of cell-mediated immunologic responsiveness following cryosurgery.
Ablin RJ
Urol Int; 1977; 32(1):65-73. PubMed ID: 70099
[TBL] [Abstract][Full Text] [Related]
58. [Immunosuppressive effect of a human serum ferroprotein of hepatic origin: alpha-2-HF-globulin].
Erard D; Rimbaut C; Auffredou MT; Galanaud P; Buffe D
C R Acad Hebd Seances Acad Sci D; 1976 Sep; 283(4):427-9. PubMed ID: 62627
[TBL] [Abstract][Full Text] [Related]
59. [Immunosuppressive effect of a human serum ferroprotein of hepatic origin, alpha 2 H globulin. Study on blastic transformation of normal lymphocytes in the presence of phytohemagglutinin].
Buffe D; Rimbaut C; Wolff E
C R Acad Hebd Seances Acad Sci D; 1975 Jan; 280(3):367-70. PubMed ID: 50890
[TBL] [Abstract][Full Text] [Related]
60. A terminal-labelling microcytotoxicity assay with 125I-iododeoxyuridine as a label for target cells.
Stirrat GM
J Immunol Methods; 1976; 12(3-4):201-18. PubMed ID: 987115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
